Trial intelligence / Profile preview

Uric Acid and Arterial Stiffness in T2D

NCT03648996Phase 2Completed

Sponsor
University of Missouri
Start
Nov 2018
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of allopurinol in type 2 diabetes mellitus (T2DM), sponsored by University of Missouri. Started Nov 2018; status: completed.

02

Drugs

allopurinol
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT03648996.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03648996.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call